PAPALEO, FRANCESCO
PAPALEO, FRANCESCO
Adolescence is the starting point of sex-dichotomous COMT genetic effects
2017 Sannino, S.; Padula, M. C.; Managò, F.; Schaer, M.; Schneider, M.; Armando, M.; Scariati, E.; Sloan-Bena, F.; Mereu, M.; Pontillo, M.; Vicari, S.; Contarini, G.; Chiabrera, C.; Pagani, M.; Gozzi, A.; Eliez, S.; Papaleo, F.
Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task
2017 Ciampoli, Mariasole; Contarini, Gabriella; Mereu, Maddalena; Papaleo, Francesco
Automatic Visual Tracking and Social Behaviour Analysis with Multiple Mice
2013 Thomas, Burne; Luca, Giancardo; Diego, Sona; Huiping, Huang; Sara, Sannino; Francesca, Managò; Diego, Scheggia; Papaleo, Francesco; Vittorio, Murino
Catechol-O-Methyltransferase Genetic Reduction Evokes Small-Bowel Neuromuscular Adaptive Changes
2016 Marsilio, Ilaria; Caputi, Valentina; Contarini, Gabriella; Mereu, Maddalena; Debetto, Patrizia; Galuppini, Francesca; Lante, Isabella; Filpa, Viviana; Orso, Genny; Rugge, Massimo; Crema, Francesca; Giaroni, Cristina; Papaleo, Francesco; Giron, MARIA CECILIA
Chronic and Acute Intranasal Oxytocin Produce Divergent Social Effects in Mice
2013 Huiping, Huang; Caterina, Michetti; Marta, Busnelli; Francesca, Managò; Sara, Sannino; Diego, Scheggia; Luca, Giancardo; Diego, Sona; Vittorio, Murino; Bice, Chini; Maria Luisa, Scattoni; Papaleo, Francesco
Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction
2022 Gregorio, Ilaria; Mereu, Maddalena; Contarini, Gabriella; Bello, Luca; Semplicini, Claudio; Burgio, Francesca; Russo, Loris; Sut, Stefania; Dall'Acqua, Stefano; Braghetta, Paola; Semenza, Carlo; Pegoraro, Elena; Papaleo, Francesco; Bonaldo, Paolo; Cescon, Matilde
COMT as a drug target for cognitive functions and dysfunctions.
2012 Scheggia, D; Sannino, S; Scattoni, Ml; Papaleo, Francesco
COMT implication in cognitive and psychiatric symptoms in chromosome 22q11 microdeletion syndrome: a selective review.
2012 Armando, M; Papaleo, Francesco; Vicari, S.
CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping
2011 M., Ingallinesi; K., Rouibi; C., Le Moine; Papaleo, Francesco; A., Contarino
Decreased motivation to eat in mu-opioid receptor-deficient mice.
2007 Papaleo, Francesco; Kieffer, Bl; Tabarin, A; Contarino, A.
Development of Knock-in Mutant Mice Carrying Human Catechol-O-Methyltransferase Met Mutation Mimicking the Functional Val158Met Polymorphism
2009 Jingshan, Chen; Papaleo, Francesco; Qingjun, Tian; Paul, Glineburg; Jian, Song; Guangping, Liu; James, Pickel; Barbara K., Lipska; Daniel R., Weinberger
Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal.
2008 Papaleo, Francesco; Ghozland, S; Ingallinesi, M; Roberts, Aj; Koob, Gf; Contarino, A.
Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal.
2007 Papaleo, Francesco; Kitchener, P; Contarino, A.
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder
2017 Mereu, M.; Contarini, G.; Buonaguro, E. F.; Latte, G.; Managò, F.; Iasevoli, F.; de Bartolomeis, A.; Papaleo, F.
Dopamine transporter genetic reduction affects small- bowel neuromuscular contractility in mice
2017 Caputi, V; Marsilio, I; Cerantola, S; Mereu, M; Contarini, G; Paquola, A; Orso, G; Giaroni, C; Papaleo, F; Giron, Mc
Dopamine–mediated immunomodulation affects choroid plexus function
2019 Castellani, G.; Contarini, G.; Mereu, M.; Albanesi, E.; Devroye, C.; D'Amore, C.; Ferretti, V.; De Martin, S.; Papaleo, F.
Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.
2011 Papaleo, Francesco; Weinberger, Dr
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways
2010 Papaleo, Francesco; F., Yang; S., Garcia; J., Chen; B., Lu; J. N., Crawley; D. R., Weinberger
Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia
2022 Mastrogiacomo, R; Trigilio, G; Devroye, C; Dautan, D; Ferretti, V; Losi, G; Caffino, L; Orso, G; Marotta, R; Maltese, F; Vitali, E; Piras, G; Forgiarini, A; Pacinelli, G; Lia, A; Rothmond, Da; Waddington, Jl; Drago, F; Fumagalli, F; De Luca, Ma; Leggio, Gm; Carmignoto, G; Weickert, Cs; Manago, F; Papaleo, F
Editorial: COMT as a drug target for nervous system disorders.
2012 Papaleo, Francesco